BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38795890)

  • 1. Chitosan-grafted folic acid decorated one-dimensional GONS: A biocompatible drug cargo for targeted co-delivery of anticancer agents.
    Sontakke AD; Gupta P; Banerjee SK; Purkait MK
    Int J Biol Macromol; 2024 Jun; 271(Pt 2):132621. PubMed ID: 38795890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficient delivery of anticancer drugs using functionalized-Ag-decorated Fe
    Romdoni Y; Prasedya ES; Kadja GTM; Kitamoto Y; Khalil M
    Biochim Biophys Acta Gen Subj; 2024 Aug; 1868(8):130643. PubMed ID: 38797254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
    Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
    Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and evaluation of galactosylated chitosan/graphene oxide nanoparticles as a drug delivery system.
    Wang C; Zhang Z; Chen B; Gu L; Li Y; Yu S
    J Colloid Interface Sci; 2018 Apr; 516():332-341. PubMed ID: 29408121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-responsive folic acid conjugated glycol chitosan nanoparticle for enhanced tumor targeting treatment.
    Jang EH; Shim MK; Kim GL; Kim S; Kang H; Kim JH
    Int J Pharm; 2020 Apr; 580():119237. PubMed ID: 32201251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
    Wu J; Tang C; Yin C
    Acta Biomater; 2017 Jan; 47():81-90. PubMed ID: 27729232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functionalized Graphene Oxide with Hepatocyte Targeting as Anti-Tumor Drug and Gene Intracellular Transporters.
    Cao X; Zheng S; Zhang S; Wang Y; Yang X; Duan H; Huang Y; Chen Y
    J Nanosci Nanotechnol; 2015 Mar; 15(3):2052-9. PubMed ID: 26413620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Smart chitosan-folate hybrid magnetic nanoparticles for targeted delivery of doxorubicin to osteosarcoma cells.
    Amiryaghoubi N; Abdolahinia ED; Nakhlband A; Aslzad S; Fathi M; Barar J; Omidi Y
    Colloids Surf B Biointerfaces; 2022 Dec; 220():112911. PubMed ID: 36274396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triformyl cholic acid and folic acid functionalized magnetic graphene oxide nanocomposites: Multiple-targeted dual-modal synergistic chemotherapy/photothermal therapy for liver cancer.
    Gong T; Wang X; Ma Q; Li J; Li M; Huang Y; Liang W; Su D; Guo R
    J Inorg Biochem; 2021 Oct; 223():111558. PubMed ID: 34329998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UiO-66 metal organic framework nanoparticles loaded carboxymethyl chitosan/poly ethylene oxide/polyurethane core-shell nanofibers for controlled release of doxorubicin and folic acid.
    Farboudi A; Mahboobnia K; Chogan F; Karimi M; Askari A; Banihashem S; Davaran S; Irani M
    Int J Biol Macromol; 2020 May; 150():178-188. PubMed ID: 32045607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a multifunctional system based on CoFe
    Arkaban H; Khajeh Ebrahimi A; Yarahmadi A; Zarrintaj P; Barani M
    Nanotechnology; 2021 May; 32(30):. PubMed ID: 33857938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chitosan Immobilization on Bio-MOF Nanostructures: A Biocompatible pH-Responsive Nanocarrier for Doxorubicin Release on MCF-7 Cell Lines of Human Breast Cancer.
    Abazari R; Mahjoub AR; Ataei F; Morsali A; Carpenter-Warren CL; Mehdizadeh K; Slawin AMZ
    Inorg Chem; 2018 Nov; 57(21):13364-13379. PubMed ID: 30351060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid-grafted bovine serum albumin decorated graphene oxide: An efficient drug carrier for targeted cancer therapy.
    Ma N; Liu J; He W; Li Z; Luan Y; Song Y; Garg S
    J Colloid Interface Sci; 2017 Mar; 490():598-607. PubMed ID: 27923144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of novel biofunctionalized chitosan decorated nanocochleates as a cancer targeted drug delivery platform.
    Bothiraja C; Rajput N; Poudel I; Rajalakshmi S; Panda B; Pawar A
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):447-461. PubMed ID: 29368543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of biocompatible nanocrystalline cellulose against folate receptors as a novel carrier for targeted delivery of doxorubicin.
    Karimian A; Yousefi B; Sadeghi F; Feizi F; Najafzadehvarzi H; Parsian H
    Chem Biol Interact; 2022 Jan; 351():109731. PubMed ID: 34728188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PEGylated DOX-coated nano graphene oxide as pH-responsive multifunctional nanocarrier for targeted drug delivery.
    Ma K; Li W; Zhu G; Chi H; Yin Y; Li Y; Zong Y; Guo Z; Wang L; Xu W; Cui C; Zhou H; Xu J
    J Drug Target; 2021 Sep; 29(8):884-891. PubMed ID: 33571019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and Development of Graphene Oxide Nanoparticle/Chitosan Hybrids Showing pH-Sensitive Surface Charge-Reversible Ability for Efficient Intracellular Doxorubicin Delivery.
    Zhao X; Wei Z; Zhao Z; Miao Y; Qiu Y; Yang W; Jia X; Liu Z; Hou H
    ACS Appl Mater Interfaces; 2018 Feb; 10(7):6608-6617. PubMed ID: 29368916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of biotin molecule targeted cancer cell drug delivery of doxorubicin loaded κ-carrageenan grafted graphene oxide nanocarrier.
    Vinothini K; Rajendran NK; Munusamy MA; Alarfaj AA; Rajan M
    Mater Sci Eng C Mater Biol Appl; 2019 Jul; 100():676-687. PubMed ID: 30948104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release of doxorubicin from graphene oxide based charge-reversal nanocarrier.
    Zhou T; Zhou X; Xing D
    Biomaterials; 2014 Apr; 35(13):4185-94. PubMed ID: 24513318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AS1411 aptamer and folic acid functionalized pH-responsive ATRP fabricated pPEGMA-PCL-pPEGMA polymeric nanoparticles for targeted drug delivery in cancer therapy.
    Lale SV; R G A; Aravind A; Kumar DS; Koul V
    Biomacromolecules; 2014 May; 15(5):1737-52. PubMed ID: 24689987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.